OrthoPediatrics Down Over 12%, on Track for Lowest Close Since April 2018 -- Data Talk

Dow Jones10-10

OrthoPediatrics Corp. $(KIDS)$ is currently at $15.69, down $2.26 or 12.59%

 

--Would be lowest close since April 9, 2018, when it closed at $15.52

--On pace for largest percent decrease since March 12, 2020, when it fell 13.99%

--Currently down four of the past five days

--Currently down two consecutive days; down 13.31% over this period

--Worst two day stretch since the two days ending April 4, 2025, when it fell 13.72%

--Down 16.41% this week; worst weekly performance since the week ending Oct. 13, 2023, when it fell 17.34%

--Down 15.33% month-to-date

--Down 32.31% year-to-date; on pace for worst year since 2022, when it fell 33.63%

--Down 78.49% from its all-time closing high of $72.93 on Nov. 5, 2021

--Down 36.25% from 52 weeks ago (Oct. 11, 2024), when it closed at $24.61

--Down 49.31% from its 52-week closing high of $30.95 on Nov. 6, 2024

--Would be a new 52-week closing low

--Traded as low as $15.38; lowest intraday level since April 5, 2018, when it hit $15.21

--Down 14.32% at today's intraday low; largest intraday percent decrease since Aug. 6, 2025, when it fell as much as 17.83%

 

All data as of 10:49:36 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

October 10, 2025 10:54 ET (14:54 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment